1. Department of Assay Development
and Compound Profiling, Harlow Research 2, GlaxoSmithKline, New Frontiers, Science Park, Third Avenue, Harlow, Essex CM19 5AD,
U.K.
2. Department of Urogenital Biology,
Cardiovascular and Urogenital Center of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania,
United States
3. Safety Assessment, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania,
United States